Debate: Should Vancomycin Remain First-Line for S. aureus?

Erin and panel present pro and con arguments on keeping vancomycin in MRSA guidelines, including resistance and dialysis access issues.

Play episode from 27:59

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!